glp-1 receptor agonists and cancer risk in adults with obesity - UF Health Cancer Center Glucagon-like peptide 1 receptor agonists
Description
However, new research presented in 2024 highlights a troubling link between certain GLP-1 drugs, such as Ozempic and Wegovy, and a condition known as drug-induced gastroparesis
doi: 10.1177/1479164111404257 Erratum in: Diab Vasc Dis Res
Overall, these results suggest that GLP-1 may regulate 3T3-L1 adipogenesis through the Akt signaling pathway
Orexigenic neurons, which stimulate appetite, produce neuropeptide Y (NPY) and agouti-related peptide (AgRP)
The most significant risk is hypoglycemia, where blood sugar drops too low
